极品新婚夜少妇真紧,亚洲精品一区二区三区中文字幕 ,久久久久人妻精品一区三寸蜜桃,日韩人妻无码一区二区三区

產(chǎn)品資料

Ubiquitin Carboxyl-Terminal Hydrolase L1 Human Recombinant

如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Ubiquitin Carboxyl-Terminal Hydrolase L1 Human Recombinant
產(chǎn)品型號(hào): PRO-576
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔

簡(jiǎn)單介紹

Ubiquitin Carboxyl-Terminal Hydrolase L1 Human Recombinant


Ubiquitin Carboxyl-Terminal Hydrolase L1 Human Recombinant  的詳細(xì)介紹
  • Product Code: PRO-576
  • Synonyms/Product Alternate Names: Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, EC 3.4.19.12, Ubiquitin thioesterase L1, Neuron cytoplasmic protein 9.5, PGP 9.5, UCHL1 Human, PGP9.5, PARK5.
  • UCHL1 (PGP9.5) belongs to a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to produce the ubiquitin monomer. Protein Gene Product (PGP9.5) is a neuron specific protein, structurally and immunologically distinct from neuron specific enolase. Human UCHL1 and UCHL3 have an extremely complicated knot structure for a protein, with five knot crossings. It is considered that the knot structure may increase a protein's resistance to degradation in the proteasome.
    The protein, which has a molecular weight of 27 kDa was first defined by high resolution two dimetional PAGE. Standard immunohistochemical techniques have demonstrated the presence of PGP9.5 in neurons and nerve fibers at all levels of the central and peripheral nervous system, in many neurodcrine cells, in segments of the renal tubules, in spermatogonia and leydig cells of the testis, in ova and in some cells of both the pregnant and non pregnant corpus luteum. A point mutation (I93M) in UCHL1 is implicated as the cause of Parkinson's disease in one kindred. On the other hand, a polymorphism (S18Y) in UCHL1 has been found to be associated with a reduced risk for Parkinson's disease. Furthermore, UCHL1 is associated with the Alzheimer's disease, and required for normal synaptic and cognitive function.

    Description: UCHL1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 223 amino acids (1-223 a.a.) and having a molecular mass of 24.8 kDa (molecular weight on SDS-PAGE will appear higher).

    Physical Appearance: Sterile Filtered clear solution.

    Formulation: The UCHL1 protein solution (1mg/ml) contains 20mM Tris-HCl buffer (pH 8.0) and 2mM EDTA.

    Stability: Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.

    Specific activity: > 150 pmole/min/ug. Measured by the hydrolysis of Ubiquitin-AMC at pH 8.0, at 37C.

  • Origin: Escherichia Coli.
  • Storage Conditions: -20 °C
  • Purity: Greater than 95.0% as determined by SDS-PAGE.
  • One-Letter Code:
    MQLKPMEINP EMLNKVLSRL GVAGQWRFVD VLGLEEESLG SVPAPACALL LLFPLTAQHE NFRKKQIEEL KGQEVSPKVY FMKQTIGNSC GTIGLIHAVA NNQDKLGFED GSVLKQFLSE TEKMSPEDRA KCFEKNEAIQ AAHDAVAQEG QCRVDDKVNF HFILFNNVDG HLYELDGRMP FPVNHGASSE DTLLKDAAKV CREFTEREQG EVRFSAVALC KAA
  • http://ndt.oxfordjournals.org/content/20/12/2714.full.pdf

產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
相關(guān)產(chǎn)品
[Tyr8]-Substance P (0.5 mg vial) PSP-4059-v
[Val5]-Angiotensin I (Bovine) (Bulk) PAN-4069
[Val5]-Angiotensin I (Bovine) (0.5 mg vial) PAN-4069-v
Bis-ACV PAC-3860-PI
[Arg8]-Vasopressin (0.5 mg vial) PVP-4085-v
[Arg8]-Vasotocin (0.5 mg vial) PVP-4192-v
[Asn1,Val5]-Angiotensin II PAN-4036
[Asn1,Val5]-Angiotensin II (0.5 mg vial) PAN-4036-v
[Asu1,6-Oxytocin (Deamino-Dicarba-Oxytocin) (0.5 mg vial) POX-4025-v
[D-Ala2,D-Leu5]-Enkephalin PEK-4115
[D-Ala2,D-Leu5]-Enkephalin (0.5 mg vial) PEK-4115-v
[D-Ala2,Met5]-Enkephalinamide (0.5 mg vial) PEK-4117-v
[D-Ala2,Met5]-Enkephalin PEK-4116
[D-Ala2,Met5]-Enkephalin (0.5 mg vial) PEK-4116-v
[D-Ala2,Met5]-Enkephalinamide PEK-4117
[Asu1,6,Arg8]-Vasopressin Deamino-Dicarba-Arginine-Vasopressin (0.5 mg vial) PVP-4026-v
[Dap3]-Ghrelin (Human, Rat, 1-5) PGH-3681-PI
[Dap3]-Ghrelin (Rat) PGH-3680-PI
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P PGH-3652-PI
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P PSP-4172
[Asu1,6,Arg8]-Vasotocin (0.5 mg vial) PVP-4027-v
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P (0.5 mg vial) PSP-4172-v
[D-Arg1,D-Trp7,9,Leu11]-Substance P PSP-4173
[D-Arg1,D-Trp7,9,Leu11]-Substance P (0.5 mg vial) PSP-4173-v
[D-Pro2,D-Trp7,9]-Substance P PSP-4113
[D-Pro2,D-Trp7,9]-Substance P (0.5 mg vial) PSP-4113-v
[D-Pro4,Trp7,9]-Substance P (4-11) PSP-4114
[D-Pro4,Trp7,9]-Substance P (4-11) (0.5 mg vial) PSP-4114-v
[D-Trp8]-Somatostatin (0.5 mg vial) PSI-4101-v
[Gly14]-Humanin (0.5 mg vial) PHN-4385-v
[Met(O)12]-ANP (Human, 1-28) (0.5 mg vial) PAF-4145-v
[Nle4, D-Phe7]-?-MSH-Amide PMC-3669-PI
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 1-34 amide) (0.5 mg vial) PTH-4180-v
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 1-34) (0.5 mg vial) PTH-4129-v
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 3-34 amide) (0.5 mg vial) PTH-4181-v
[Pmp1, Tyr(Me)2]-Arg8-Vasopressin (0.5 mg vial) PVP-4203-v
[Pyr1]-Apelin-13 (Human, Bovine) (0.5 mg vial) PAP-4361-v
[Pyr3]-Amyloid ?-Protein (Human, 3-42) (0.5 mg vial) PAB-4367-v
[Pyr33]-Pancreastatin (Porcine, 33-49) (0.5 mg vial) PPP-4186-v
[Sar1,Ala8]-Angiotensin II PAN-4035
[Sar1,Ala8]-Angiotensin II (0.5 mg vial) PAN-4035-v
[Sar1,Ile8]-Angiotensin II PAN-4016
[Sar1,Ile8]-Angiotensin II (0.5 mg vial) PAN-4016-v
Acetyl-Myelin Basic Protein (Human, Porcine, Rat, 1-11) PMB-3658-PI
Acetyl-Myelin Basic Protein (Mouse, 1-11) PMB-3657-PI
[Leu31, Pro34]-NPY (Porcine) (0.1mg vial) PNP-4314-s
[Sar1,Thr8]-Angiotensin II PAN-4102
[Sar1,Thr8]-Angiotensin II (0.5 mg vial) PAN-4102-v
[Sar1,Val5,Ala8]-Angiotensin II PAN-4071
[Sar1,Val5,Ala8]-Angiotensin II (0.5 mg vial) PAN-4071-v

滬公網(wǎng)安備 31011202007343號(hào)